Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals

News Summary: New LC-MS system delivers accurate and reproducible results for multi-attribute monitoring of biologics. Eliminates analyte-to-metal surface interactions greatly enhancing recovery of hard-to-detect sample analytes. Gives more scientists greater access to MS data to improve quality, reduce costs, and ultimately help get medicines to patients faster. MILFORD, Mass. -- Waters Corporation (NYSE:WAT) today introduced [...]

BIO-TECHNE LAUNCHES EXCELLERATE™ IPSC EXPANSION MEDIUM

A novel animal component-free medium that supports robust expansion and maintenance of human pluripotent stem cells. MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) Bio-Techne announced the launch of a new medium for the expansion and maintenance of induced pluripotent stem cells (iPSCs) for use in both research and translational workflows. The ExCellerate™ iPSC Expansion Medium is [...]

Insightful Science Acquires FCS Express, Strengthening its Leadership Position as The Cloud for Scientific Discovery

FCS Express expands the flow cytometry solutions within the Insightful Science platform, enabling world-class data-driven scientific research in academia and biopharma and clinical analysis in regulated enterprise environments. Insightful Science is the leading end-to-end scientific research platform with both the broadest and deepest scientific capabilities across chemistry and biology. The unique platform accelerates innovation and [...]

Twist Bioscience Continues Commitment to Deliver Synthetic RNA Controls, now to Fight Delta Plus Variants of COVID-19

-- Latest Variants of Concern, AY.1 and AY.2 Controls Now Available for Development of Accurate Diagnostic Tests -- SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has started shipping its synthetic RNA reference [...]

CEM Corporation and AmbioPharm Form U.S. Partnership for GMP Peptide Production

Highlights: Extremely Rapid Peptide Production Large-Scale Microwave Peptide Synthesis Novel Green Chemistry Methodology (Matthews, NC & North Augusta, SC) – CEM Corporation and AmbioPharm, Inc. are excited to announce the formation of a partnership for production of GMP peptides for the global market. The partnership will involve an exclusive1 use of CEM’s large-scale microwave peptide synthesis [...]

Biognosys Enters Collaboration with Leading Life Science Company to Advance Next-Generation Proteomics

Under the agreement, Evotec will utilize Biognosys’ proprietary proteomics data analysis platform to accelerate and de-risk drug development September 14th, 2021 – SCHLIEREN (Zurich, Switzerland) – Biognosys, an innovator and leader in next-generation proteomics technology and solutions for life sciences research, announced today that they have entered a collaboration with Evotec, a life science company [...]

Inventors of biolayer interferometry technology launch a next gen platform and novel biosensors

PALO ALTO, Calif. -- Gator Bio, Inc. announced today the launch of the GatorPlus, a next generation biolayer interferometry (BLI) instrument and two new biosensor products, Gator™ Flex SA Kit and Gator™ AAVX probe. The GatorPlus adds to the currently available GatorPrime instrument; and the new Gator™ Flex SA Kit and Gator™ AAVX probe expand the off the shelf biosensor portfolio to 14 products for [...]

Benchling Expands into Early Development Market to Accelerate Delivery of Breakthrough Products

R&D Cloud takes on legacy ELN, LIMS, and LES software with a single unified solution SAN FRANCISCO — Benchling, pioneer of the R&D Cloud powering the biotechnology industry, today announced the company’s entry into the Early Development market, launching new solutions that allow scientists to seamlessly move from research through development within a single system [...]

Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

Lakewood, Colorado – Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, announced today that it has entered into a definitive agreement to acquire Agena Bioscience, Inc. for a cash purchase price of $300 million, subject to customary purchase [...]

Cresset Discovery Services enters collaboration with the University of Newcastle, Australia, to repurpose therapeutics against oncology targets

Cambridge, UK – 14 September 2021 – Cresset Discovery Services, provider of contract research services for early phase of drug discovery, has announced it will collaborate with the University of Newcastle, Australia, to focus on drug reprofiling against oncology targets. The work will build on research led by award-winning molecular biologist, Associate Professor Nikola Bowden. Nikola is [...]

Access IBO on Knowledge Center